BlackRock
GLSI icon

BlackRock’s Greenwich LifeSciences GLSI Stock Holding History

BlackRock’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
485,854
+51,994
+12% +$1.27M ﹤0.01% 3603
2026
Q1 		$10.4M Buy
433,860
+62,396
+17% +$1.63M ﹤0.01% 3487
2025
Q4 		$7.8M Buy
371,464
+8,165
+2% +$85.9K ﹤0.01% 3605
2025
Q3 		$3.61M Sell
363,299
-3,882
-1% -$43.8K ﹤0.01% 3910
2025
Q2 		$3.33M Buy
367,181
+14,990
+4% +$143K ﹤0.01% 3926
2025
Q1 		$3.36M Sell
352,191
-5,653
-2% -$68.6K ﹤0.01% 3804
2024
Q4 		$4.02M Buy
357,844
+7,700
+2% +$103K ﹤0.01% 3817
2024
Q3 		$5.03M Buy
350,144
+41,235
+13% +$611K ﹤0.01% 3694
2024
Q2 		$5.33M Buy
308,909
+252,450
+447% +$3.69M ﹤0.01% 3666
2024
Q1 		$1.13M Sell
56,459
-689
-1% -$8.5K ﹤0.01% 4169
2023
Q4 		$601K Buy
57,148
+1,158
+2% +$11.6K ﹤0.01% 4388
2023
Q3 		$495K Sell
55,990
-1,585
-3% -$14.9K ﹤0.01% 4427
2023
Q2 		$555K Buy
57,575
+823
+1% +$9.2K ﹤0.01% 4456
2023
Q1 		$783K Buy
56,752
+5,830
+11% +$92.5K ﹤0.01% 4405
2022
Q4 		$774K Buy
50,922
+111
+0.2% +$1.27K ﹤0.01% 4495
2022
Q3 		$462K Sell
50,811
-240
-0.5% -$2.22K ﹤0.01% 4753
2022
Q2 		$433K Sell
51,051
-185,204
-78% -$2.12M ﹤0.01% 4813
2022
Q1 		$4.64M Sell
236,255
-1,704
-0.7% -$34.4K ﹤0.01% 4007
2021
Q4 		$5.79M Buy
237,959
+20,105
+9% +$673K ﹤0.01% 3934
2021
Q3 		$8.51M Buy
217,854
+106
+0% +$4.43K ﹤0.01% 3744
2021
Q2 		$9.79M Buy
217,748
+154,208
+243% +$5.83M ﹤0.01% 3652
2021
Q1 		$2.17M Buy
63,540
+4,244
+7% +$144K ﹤0.01% 4267
2020
Q4 		$2.16M Buy
+59,296
New +$865K ﹤0.01% 4014

Other funds holding GLSI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock's GLSI Position: Q2 2026 in Review

BlackRock increased its Greenwich LifeSciences (GLSI) stake by 12% in Q2 2026, buying an estimated $1.27M and bringing the position to 485,854 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

BlackRock first reported a position in GLSI in Q4 2020 and has held it in 23 quarters since. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • BlackRock held 485,854 shares of Greenwich LifeSciences worth $11.4M as of Q2 2026.
  • BlackRock bought 51,994 Greenwich LifeSciences shares in Q2 2026, an estimated $1.27M.
  • Greenwich LifeSciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3603 holding.
  • BlackRock first reported a position in Greenwich LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.